Systems announced six-month findings from the single-arm AVG cohort of its WRAPSODY Arteriovenous Access Efficacy pivotal ...

WRAPSODY achieves 82% target lesion primary patency at six months in the single-arm cohort of the US pivotal trialSOUTH JORDAN, Utah, Nov.

The WAVE trial was designed to evaluate the efficacy ... The proportion of AVG patients who were free from an adverse event was higher than the safety PG (95.4% vs. 89.0%, p=0.0162).

The proportion of AVG patients who were free from an adverse event was higher than the safety PG (95.4% vs. 89.0%, p=0.0162). “In light of the historically low patency rates for AVG patients, the ...

Merit Medical Systems, Inc. announced 6-month findings from the single-arm arteriovenous graft (AVG) cohort of the WAVE pivota ...

Check out our Lions vs. Bears how-to-watch guide to learn when they play and what free live streams are available ahead of ...